Powder represents 68.0% within the form segment and epilepsy accounts for 63.0% of the application category in 2026. The carbamazepine market is estimated at USD 217.74 million in 2026, is projected to reach USD 355.49 million by 2036 and is forecast to post a 5.0% CAGR between 2026 and 2036.